The neurosteroid dehydroepiandrosterone (DHEA) protects the retina from AMPA-induced excitotoxicity: NGF TrkA receptor involvement

Neuropharmacology

Volumn 62, Issue 5-6, 2012, Pages 2106-2117

  Kokona, Despina ^a   Charalampopoulos, Ioannis ^a   Pediaditakis, Iosif ^a   Gravanis, Achille ^a   Thermos, Kyriaki ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Excitotoxicity; Neuroprotection; Neurosteroids; Neurotrophin; NGF; Retina

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALBINDIN; CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; PRASTERONE; PROTEIN TYROSINE KINASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; EXCITOTOXICITY; FEMALE; FLOW RATE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUELLER CELL; NEUROPROTECTION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RETINA; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; VITREOUS BODY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DEHYDROEPIANDROSTERONE; EXCITATORY AMINO ACID AGONISTS; FEMALE; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; RETINA;

EID: 84857055550     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.01.006     Document Type: Article

References (36)

1. N. Andres, Y. Malpesa, M.J. Rodriguez, and N. Mahy Low sensitivity of retina to AMPA- induced calcification J. Neurosci. Res. 72 2003 543 548 (Pubitemid 36523429)
2. D.A. Antonetti, A.J. Barber, S.K. Bronson, W.M. Freeman, T.W. Gardner, L.S. Jefferson, M. Kester, S.R. Kimball, J.K. Krady, K.F. LaNoue, C.C. Norbury, P.G. Quinn, L. Sandirasegarane, and I.A. Simpson Seeing beyond glucose-induced microvascular disease Diabetes 55 2006 2401 2411 (Pubitemid 44871140)
3. Y. Bai, P. Dergham, H. Nedev, A. Galan, J.C. Rivera, S. ZhiHua, H.M. Mehta, S.B. Woo, M.V. Sarunic, K.E. Neet, and H.U. Saragovi In chronic and in acute models of retinal neurodegeneration TrkA activity is neuroprotective while p75NTR activity is neurotoxic through a paracrine mechanism J. Biol. Chem. 285 2010 39392 39400
4. A.J. Barber A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 283 290 (Pubitemid 36351495)
5. C. Bucolo, and F. Drago Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites Eur. J. Pharmacol. 498 2004 111 114 (Pubitemid 39208068)
6. T. Calogeropoulou, N. Avlonitis, V. Minas, X. Alexi, A. Pantzou, I. Charalampopoulos, M. Zervou, V. Vergou, E.S. Katsanou, I. Lazaridis, M.N. Alexis, and A. Gravanis Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity J. Med. Chem. 52 2009 6569 6587
7. C. Cascio, D. Russo, G. Drago, G. Galizzi, R. Passantino, R. Guarneri, and P. Guarneri 17beta-estradiol synthesis in the adult male rat retina Exp. Eye Res. 85 2007 166 172 (Pubitemid 47017260)
8. I. Charalampopoulos, C. Tsatsanis, E. Dermitzaki, V.I. Alexaki, E. Castanas, A.N. Margioris, and A. Gravanis Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins Proc. Nat. Acad. Sci. USA 101 2004 8209 8214 (Pubitemid 38698079)
9. I. Charalampopoulos, E. Dermitzaki, L. Vardouli, C. Tsatsanis, C. Stournaras, A.N. Margioris, and A. Gravanis Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization Endocrinology 146 2005 3309 3318 (Pubitemid 41058102)
10. I. Charalampopoulos, V.I. Alexaki, I. Lazaridis, E. Dermitzaki, N. Avlonitis, C. Tsatsanis, T. Calogeropoulou, A.N. Margioris, E. Castanas, and A. Gravanis G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone FASEB J. 20 2006 577 579 (Pubitemid 46671255)
11. I. Charalampopoulos, E. Remboutsika, A. Margioris, and A. Gravanis Neurosteroids as endogenous modulators of neurogenesis and neuronal survival Trends Endocrinol. Metab. 19 2008 300 307
12. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
13. N.A. Compagnone, and S.H. Mellon Neurosteroids: biosynthesis and function of these novel neuromodulators Front. Neuroendocrinol. 21 2000 1 56 (Pubitemid 30105920)
14. C. Corpéchot, P. Robel, M. Axelson, J. Sjövall, and E.E. Baulieu Characterization and measurement of dehydroepiandrosterone sulfate in rat brain Proc. Natl. Acad. Sci. USA 78 1981 4704 4707
15. N. Ferrara, L. Damico, N. Shams, H. Lowman, and R. Kim Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 2006 859 870 (Pubitemid 44547437)
16. G. Juhász-Vedres, E. Rózsa, G. Rákos, M.B. Dobszay, Z. Kis, J. Wölfling, J. Toldi, A. Párducz, and T. Farkas Dehydroepiandrosterone sulfate is neuroprotective when administered either before or after injury in a focal cortical cold lesion model Endocrinology 147 2006 683 686 (Pubitemid 43112983)
17. 2 analogs on AMPA-induced neurotoxicity in rat retina Invest. Ophthalmol. Vis. Sci. 49 2008 3080 3089
18. F. Kiagiadaki, M. Savvaki, and K. Thermos Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity Neuropharmacology 58 2010 297 303
19. Kiagiadaki, F., 2009. In vivo study of the neuroprotective actions of somatostatin in a model of retinal excitotoxicity. PhD Thesis, University of Crete, Heraklion, Crete.
20. V.G. Kimonides, N.H. Khatibi, C.N. Svendsen, M.V. Sofroniew, and J. Herbert Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity Proc. Natl. Acad. Sci. USA 95 1998 1852 1857 (Pubitemid 28103483)
21. K. Kurata, M. Takebayashi, S. Morinobu, and S. Yamawaki Beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-d-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms J. Pharmacol. Exp. Ther. 311 2004 237 245 (Pubitemid 39287803)
22. A. Lambiase, L. Aloe, M. Centofanti, V. Parisi, F. Mantelli, V. Colafrancesco, G.L. Manni, M.G. Bucci, S. Bonini, and R. Levi-Montalcini Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma Proc. Nat. Acad. Sci. USA 106 2009 13469 13474
23. A. Lambiase, M. Coassin, P. Tirassa, F. Mantelli, and L. Aloe Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report Ann. Ist. Super. Sanita 45 2009 439 442
24. A. Lambiase, F. Mantelli, M. Sacchetti, S. Rossi, L. Aloe, and S. Bonini Clinical applications of NGF in ocular diseases Arch. Ital. Biol. 149 2011 283 292
25. A receptors Stroke 31 2000 1953 1957 (Pubitemid 30620479)
26. I. Lazaridis, I. Charalampopoulos, V.I. Alexaki, N. Avlonitis, I. Pediaditakis, P. Efstathopoulos, T. Calogeropoulou, E. Castanas, and A. Gravanis Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis PLoS Biol. 9 2011 e1001051
27. F. Lebrun-Julien, B. Morquette, A. Douillette, H.U. Saragovi, and A. Di Polo Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells Mol. Cell. Neurosci. 40 2009 410 420
28. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N. Engl. J. Med. 330 1994 613 622
29. C. Meads, C. Salas, T. Roberts, D. Moore, A. Fry-Smith, and C. Hyde Clinical effectiveness and cost utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation Health Technol. Assess. 7 9 2001
30. S.H. Mellon Neurosteroid regulation of central nervous system development Pharmacol. Ther. 116 2007 107 124 (Pubitemid 47391034)
31. N.N. Osborne, R.J. Casson, J.P. Wood, G. Chidlow, M. Graham, and J. Melena Retinal ischemia: mechanisms of damage and potential therapeutic strategies Prog. Retina. Eye Res. 23 2004 91 147 (Pubitemid 38180539)
32. C. Romano, M.T. Price, and J.W. Olney Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina J. Neurochem. 65 1995 59 67
33. C. Tapas, and S. Wadhwa Neurotrophin receptors (Trk A, Trk B, and Trk C) in the developing and adult human retina Dev. Brain Res. 117 1999 179 189 (Pubitemid 29531509)
34. P. van Wijngaarden, D.J. Coster, and K.A. Williams Inhibitors of ocular neovascularization: promises and potential problems JAMA 293 2005 1509 1513 (Pubitemid 40393297)
35. A. Vasilaki, and K. Thermos Somatostatin analogues as therapeutics in retinal disease Pharmacol. Ther. 122 2009 324 333
36. E. Vecino, E. Caminos, M. Ugarte, D. Martín-Zanca, and N.N. Osborne Immunohistochemical distribution of neurotrophins and their receptors in the rat retina and the effects of ischemia and reperfusion Gen. Pharmacol. 30 1998 305 314 (Pubitemid 28046499)